Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy

计划入组 42 人 · 首次发布于 2023 年 4 月 20 日

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

计划入组 33 人 · 首次发布于 2013 年 9 月 13 日

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

计划入组 29 人 · 首次发布于 2023 年 4 月 7 日

Interleukin-1-alpha(Otsuka Pharmaceutical Co., Ltd.)

PAR2 inhibitors(Otsuka)

Pancreatic Cells Derived From Pigs therapy(Otsuka Pharmaceutical Factory)

Otsuka Pharmaceutical Europe Ltd

Belgium

OTSUKA AMERICA PHARMACEUTICAL

United States

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

United States

European Commission Approves Rxulti for Adolescent Schizophrenia Treatment

Otsuka Pharmaceutical Acquires Cantargia's CAN10 Antibody Program for $33 Million Upfront in Autoimmune Disease Deal

Otsuka Pharmaceutical Secures Global Rights to HBM7020 BCMAxCD3 Bispecific T-Cell Engager for Autoimmune Diseases